GlaxoSmithKline discusses automation of study design and delivery lifecycle and leveraging low-code automation.
Appian sits down with GlaxoSmithKline to discuss automation of study design and delivery lifecycle for life sciences organizations, and how leveraging low code platform capabilities together with agile development methodology could enable rapid development of solutions for increased efficiency and effectiveness and readiness in pandemics like COVID-19.
In this webinar, you will hear about the most effective ways for tracking documentations, milestones, and other components of the study design and planning process.
- Automating processes that were previously manual to enable more efficient and collaborative processes
- Improving transparency of data and decisions to improve protocol design and predictable protocol delivery
- Tracking documentations, milestones, and other components of study design and planning process
Add Comment